Publications

Low clinical conversion rate in clinically isolated syndromes (CIS) patients - diagnostic benefit of McDonald 2010 criteria?, Eur J Neurol. 2017, ID, ENE13476, DOI, 10.1111/ene.13476

Feeling older, walking slower - but only if someone is watching. Subjective age is associated with walking speed in the laboratory, but not in real life, European Journal of Ageing, December 2018, Volume 15, Issue 4, pp 425-433

Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancers

Walking on the Moon, ELS European Lunar Symposium, http,//els2016.arc.nasa.gov/, 18-19. May 2016 Amsterdam

Biotechnologie und Krebs Biotechnologie und Krebs - Teil 2, Epigenetik, Proteomik, CHAZ, 17. Jahrgang. 3. Heft, 2016 CHAZ (2016) 17, 125-130, Kaden Verlag, Heidelberg

Motorisches Fieberthermometer- Wohin mit den Sensoren?, Orthopädieschuhtechnik, Ausgabe 10/2015

Motorisches Fieberthermometer - Wohin mit den Sensoren?

Generating Evidence from Historical Data Using Robust Prognostic Matching, Experience from Multiple Sclerosis, in Re-Engineering Clinical Trials, Schüler P, Buckley B, ISBN, 9780124202467, ELSEVIER, 2014, S. 177-185

On the Measurement of the Disease Status in Clinical Trials, Lessons from Multiple Sclerosis, , in Re-Engineering Clinical Trials, Schüler P, Buckley B, ISBN, 9780124202467, ELSEVIER, 2014, S. 171-175

Association between walking speed and age in healthy, free-living individuals using mobile accelerometry - a cross-sectional study

Development and validation of a new method to measure walking speed in free-living environments using the actibelt platform

Surrogate endpoints for EDSS worsening in multiple sclerosis, A meta-analytic approach, Measuring disability in relapsing-remitting MS

Imagine a world without cancer, BMC Cancer.2014, 14,186, DOI, 10.1186/1471-2407-14-186

Validating Predictors of Disease Progression in a Large Cohort of Primary-Progressive Multiple Sclerosis based on a systematic literature review

Physical Activity in Finnish Persons with Multiple Sclerosis

Werkstattgespräch - BMBF/VDI/VDE

Response to, DELEGATED ACT ON POST-AUTHORISATION EFFICACY STUDIES

Progressive Adaptation in Physical Activity and Neuromuscular Performance during 520d Confinement

A Web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis

Robust Prognostic Matching - Do Virtual Placebo Groups solve the Placebo Problem in Multiple Sclerosis?

< >